ATLANTA, GA. — MIV Therapeutics, a Canadian-based developer of coatings for medical devices such as stents, is opening a U.S. operation. It will be based in Atlanta.
Mark Landy, a medical device analyst, was recently named as president of the company and will be based in Atlanta.
MIV is based in Vancouver, British Columbia.
“The opening of the Atlanta office expands our operations and capability to bring a robust pipeline of novel therapeutic solutions to the high-growth cardiovascular treatment marketplace,” said Alan Lindsay, the firm’s chief executive officer. “In conjunction with Mark’s leadership, our new U.S. office will be dedicated to raising our profile and establishing new strategic partnerships that will help us to realize MIVT’s full medical, technological, business and financial potential within the United States, North America, and around the world.”
MIV develops biocompatible and polymer-free coatings for vascular stents, internal drug delivery systems and other medical applications.
